The present invention provides the compound N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)- quinazolin-6-yl]-acrylamide that is an irreversible inhibitor of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis using the compound N-[4-(3-chloro-4-fluoro-pheylamino)-7-(3-morpholin-4-yl-propoxy)- quinazolin-6-yl]-acrylamide, and a pharmaceutical composition that contains the compound N-[4-(3-chloro-4-fluoro-phenylamino-7-(3-morpholin-4-yl-propoxy-qu inazolin-6-yl]-acrylamide. 15 claims.
展开▼
